Zura Bio Ltd reports results for the quarter ended in June - Earnings Summary

Zura Bio

14/08/2023 22:02

* Zura Bio Ltd  ZURA.OQ  reported a quarterly adjusted loss
of
$1.31​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 25 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Zura Bio Ltd's reported EPS for the quarter was a loss of
$1.31​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Zura Bio Ltd shares had fallen by 16.6% this quarter and
lost 33.0% so far this year.
    * The company reported a quarterly loss of $44.9 million.
    * Wall Street's median 12-month price target for Zura Bio
Ltd is
$20.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.25          -1.31          Missed